Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Novo Nordisk names for other drugs.
Recalls
- Mar 22, 2021 · Class I · Novo Nordisk Inc
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots: KP51207 exp 06/30/2022; KP52618 exp 10/31/2022 - Mar 22, 2021 · Class I · Novo Nordisk Inc
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots: KS6BF84, Exp 06/30/2022 - Mar 22, 2021 · Class I · Novo Nordisk Inc
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots: KS6BX63 exp 10/31/2022; KS6AK76 exp 05/31/2022; KS6BR92 exp 09/30/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Insulin Aspart: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 100 [iU] per 1 mL
- Approval
- BLA BLA208751
- On the market since
- Oct 20, 2017
- Package NDCs
0169-3201-110169-3201-90- Official label
- DailyMed (National Library of Medicine), updated Jun 21, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?